Bafna Pharmaceuticals Ltd Financial Statements

BAFNAPH Profit and Loss

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2019 Mar-2018 Mar-2017
Revenue 42.50 43.40 47.20 65
yoy growth (%) (2) (8.10) (27) (24)
Raw materials (20) (28) (38) (52)
As % of sales 47.10 64.10 81.20 79.90
Employee costs (10) (9) (7.50) (6.80)
As % of sales 24.10 20.80 15.80 10.50
Other costs (11) (20) (37) (12)
As % of sales 25.90 45.90 77.50 18.50
Operating profit 1.22 (13) (35) (5.80)
OPM 2.88 (31) (74) (8.90)
Depreciation (3.30) (3.50) (4) (4.20)
Interest expense (0.10) (2.10) (6.90) (11)
Other income 0.26 0.65 31.30 1.14
Profit before tax (1.90) (18) (15) (20)
Taxes -- (1.10) (2.20) 0.90
Tax rate -- 5.84 14.90 (4.40)
Minorities and other (0.30) (0.50) 0.17 --
Adj. profit (2.20) (20) (17) (19)
Exceptional items (23) 1.01 -- --
Net profit (25) (19) (17) (19)
yoy growth (%) 31 12.80 (14) 38.70
NPM (58) (44) (35) (30)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

Open Demat Account
  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity